Jentashapir Journal of Health Research

Published by: Kowsar

Comparison of Levetiracetam With Sodium Valproate in Controlling Seizure in Patients Suffering From Juvenile Myoclonic Epilepsy

Davood Kashipazha 1 , Seyed Ehsan Mohammadiany Nejad 1 , Fatemeh Sadr 1 , * , Shahram Tarahomi 1 and Soroush Sadr 2
Authors Information
1 Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Medical School, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jentashapir Journal of Health Research: August 01, 2014, 5 (4); e21875
  • Published Online: August 11, 2014
  • Article Type: Research Article
  • Received: March 1, 2014
  • Revised: April 12, 2014
  • Accepted: April 27, 2014
  • DOI: 10.17795/jjhr-21875

To Cite: Kashipazha D, Mohammadiany Nejad S E, Sadr F, Tarahomi S, Sadr S. Comparison of Levetiracetam With Sodium Valproate in Controlling Seizure in Patients Suffering From Juvenile Myoclonic Epilepsy, Jentashapir J Health Res. 2014 ; 5(4):e21875. doi: 10.17795/jjhr-21875.

Copyright © 2014, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Mantoan L, Walker M. Treatment options in juvenile myoclonic epilepsy. Curr Treat Options Neurol. 2011; 13(4): 355-70[DOI][PubMed]
  • 2. Faught E. Epilepsy case studies. Neurol Clin. 2006; 24(2): 291-307[DOI][PubMed]
  • 3. Auvin S. Treatment of juvenile myoclonic epilepsy. CNS Neurosci Ther. 2008; 14(3): 227-33[DOI][PubMed]
  • 4. Specchio LM, Gambardella A, Giallonardo AT, Michelucci R, Specchio N, Boero G, et al. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy. Epilepsy Res. 2006; 71(1): 32-9[DOI][PubMed]
  • 5. Abou-Khalil BW, Gallagher MJ, Macdonald RL. Neurology in Clinical Practice. 2012; : 1597
  • 6. Auvin S. Treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy. Neuropsychiatr Dis Treat. 2007; 3(6): 729-34[PubMed]
  • 7. Verrotti A, Cerminara C, Coppola G, Franzoni E, Parisi P, Iannetti P, et al. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Dev Med Child Neurol. 2008; 50(1): 29-32[DOI][PubMed]
  • 8. Montouris G, Abou-Khalil B. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? Epilepsia. 2009; 50 Suppl 8: 16-20[DOI][PubMed]
  • 9. Alfradique I, Vasconcelos MM. Juvenile myoclonic epilepsy. Arq Neuropsiquiatr. 2007; 65(4B): 1266-71
  • 10. Sharpe DV, Patel AD, Abou-Khalil B, Fenichel GM. Levetiracetam monotherapy in juvenile myoclonic epilepsy. Seizure. 2008; 17(1): 64-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments